Looks like you’re on the UK site. Choose another location to see content specific to your location

Cleerly Secures $106M for AI Heart Technology Expansion
Cleerly, a leading innovator in medical technology, has successfully raised $106 million to expand its AI-driven tool designed to revolutionise heart disease diagnosis. This significant investment, led by Insight Partners and Battery Ventures, underscores the market’s confidence in Cleerly’s ground-breaking technology that aims to enhance the accuracy of heart disease detection, potentially benefiting millions by transforming preventative cardiology.
In the competitive landscape of medical devices, Cleerly stands out with its sophisticated artificial intelligence-powered platform that analyses coronary computed tomography angiography (CCTA). This tool generates 3D models of coronary arteries, offering detailed insights into plaque build-up and vessel narrowing. Unlike traditional methods, Cleerly’s system automates the arduous task of CCTA analysis, significantly reducing the need for invasive coronary angiograms by up to 86% in some studies. The company’s success in securing Medicare coverage for this technology further attests to its clinical efficacy and potential to reshape cardiac care by providing a non-invasive, precise diagnostic option.
With a total of $223 million raised, this latest funding enables Cleerly to scale its operations and further validate its technology through clinical trials. The infusion of capital will accelerate its commercial growth and support ongoing research into advancing AI applications in cardiology. As Cleerly’s CEO, James Min, highlighted, the strategic expansion comes at a pivotal time with impending Medicare coverage and the introduction of procedural codes for this cutting-edge technology, heralding a new era of enhanced heart disease management and patient care.
Contact Mark for more details.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard